To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants
Clinical trial NCT07279233 · COMPLETED
Trial details
- NCT number
- NCT07279233
- Sponsor
- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-15
- Primary completion
- 2026-02-27
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.